199 related articles for article (PubMed ID: 32807064)
21. Synthesis and antiproliferative activity of new coumarin-based benzopyranone derivatives against human tumor cell lines.
Musa MA; Zhou A; Sadik OA
Med Chem; 2011 Mar; 7(2):112-20. PubMed ID: 21222615
[TBL] [Abstract][Full Text] [Related]
22. DNA-binding activity and cytotoxic and cell-cycle arrest properties of some new coumarin derivatives: a multispectral and computational investigation.
Khosravifar F; Dehghan G; Bidoki SK; Mahdavi M
Luminescence; 2020 Feb; 35(1):98-106. PubMed ID: 31475787
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, biological evaluation and molecular docking of novel chalcone-coumarin hybrids as anticancer and antimalarial agents.
Pingaew R; Saekee A; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Eur J Med Chem; 2014 Oct; 85():65-76. PubMed ID: 25078311
[TBL] [Abstract][Full Text] [Related]
24. Design, Synthesis and Biological Evaluation of Novel Coumarin-Based Hydroxamate Derivatives as Histone Deacetylase (Hdac) Inhibitors with Antitumor Activities.
Yang F; Zhao N; Song J; Zhu K; Jiang CS; Shan P; Zhang H
Molecules; 2019 Jul; 24(14):. PubMed ID: 31311163
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and evaluation of coumarin derivatives against human lung cancer cell lines.
Weng KG; Yuan YL
Braz J Med Biol Res; 2017 Sep; 50(11):e6455. PubMed ID: 28902928
[TBL] [Abstract][Full Text] [Related]
26. Water Soluble Coumarin Quaternary Ammonium Chlorides: Synthesis and Biological Evaluation.
Karataş MO; Noma SAA; Gürses C; Balcıoğlu S; Ateş B; Alıcı B; Çakır Ü
Chem Biodivers; 2020 Sep; 17(9):e2000258. PubMed ID: 32638471
[TBL] [Abstract][Full Text] [Related]
27. Recent developments of C-4 substituted coumarin derivatives as anticancer agents.
Dandriyal J; Singla R; Kumar M; Jaitak V
Eur J Med Chem; 2016 Aug; 119():141-68. PubMed ID: 27155469
[TBL] [Abstract][Full Text] [Related]
28. Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors.
Ma CC; Liu ZP
Anticancer Agents Med Chem; 2017; 17(3):395-403. PubMed ID: 26902599
[TBL] [Abstract][Full Text] [Related]
29. In vitro anti-tumour and cyto-selective effects of coumarin-3-carboxylic acid and three of its hydroxylated derivatives, along with their silver-based complexes, using human epithelial carcinoma cell lines.
Thati B; Noble A; Creaven BS; Walsh M; McCann M; Kavanagh K; Devereux M; Egan DA
Cancer Lett; 2007 Apr; 248(2):321-31. PubMed ID: 16996681
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of novel diazaphosphinanes coumarin derivatives with promoted cytotoxic and anti-tyrosinase activities.
Gardelly M; Trimech B; Belkacem MA; Harbach M; Abdelwahed S; Mosbah A; Bouajila J; Ben Jannet H
Bioorg Med Chem Lett; 2016 May; 26(10):2450-2454. PubMed ID: 27080182
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids.
Kraljević TG; Harej A; Sedić M; Pavelić SK; Stepanić V; Drenjančević D; Talapko J; Raić-Malić S
Eur J Med Chem; 2016 Nov; 124():794-808. PubMed ID: 27639370
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, Antioxidant and Antiproliferative Evaluation, Molecular Docking and DFT Studies of Some Novel Coumarin and Fused Coumarin Derivatives.
Gouda MAS; Salem MAI; Marzouk MI; Mahmoud NFH; Ismail MF
Chem Biodivers; 2023 Jul; 20(7):e202300706. PubMed ID: 37321977
[TBL] [Abstract][Full Text] [Related]
33. Some new indole-coumarin hybrids; Synthesis, anticancer and Bcl-2 docking studies.
Kamath PR; Sunil D; Ajees AA; Pai KS; Das S
Bioorg Chem; 2015 Dec; 63():101-9. PubMed ID: 26469742
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of novel building blocks of benzosuberone bearing coumarin moieties and their evaluation as potential anticancer agents.
Yadagiri B; Holagunda UD; Bantu R; Nagarapu L; Kumar CG; Pombala S; Sridhar B
Eur J Med Chem; 2014 May; 79():260-5. PubMed ID: 24742385
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, computational studies and antiproliferative activities of coumarin-tagged 1,3,4-oxadiazole conjugates against MDA-MB-231 and MCF-7 human breast cancer cells.
Dhawan S; Kerru N; Awolade P; Singh-Pillay A; Saha ST; Kaur M; Jonnalagadda SB; Singh P
Bioorg Med Chem; 2018 Nov; 26(21):5612-5623. PubMed ID: 30360952
[TBL] [Abstract][Full Text] [Related]
36. Novel coumarin-dihydropyrazole thio-ethanone derivatives: design, synthesis and anticancer activity.
Wu XQ; Huang C; Jia YM; Song BA; Li J; Liu XH
Eur J Med Chem; 2014 Mar; 74():717-25. PubMed ID: 24119869
[TBL] [Abstract][Full Text] [Related]
37. Synthetic Mono/di-halogenated Coumarin Derivatives and Their Anticancer Properties.
Kasumbwe K; Venugopala KN; Mohanlall V; Odhav B
Anticancer Agents Med Chem; 2017; 17(2):276-285. PubMed ID: 27671300
[TBL] [Abstract][Full Text] [Related]
38. Application of a Validated QSTR Model for Repurposing COX-2 Inhibitor Coumarin Derivatives as Potential Antitumor Agents.
Tugcu G; Sipahi H; Aydin A
Curr Top Med Chem; 2019; 19(13):1121-1128. PubMed ID: 31210111
[TBL] [Abstract][Full Text] [Related]
39. Tacrine-Coumarin Derivatives as Topoisomerase Inhibitors with Antitumor Effects on A549 Human Lung Carcinoma Cancer Cell Lines.
Konkoľová E; Hudáčová M; Hamuľaková S; Jendželovský R; Vargová J; Ševc J; Fedoročko P; Kožurková M
Molecules; 2021 Feb; 26(4):. PubMed ID: 33672694
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, cytotoxicity and mechanism of novel dihydroartemisinin-coumarin hybrids as potential anti-cancer agents.
Yu H; Hou Z; Tian Y; Mou Y; Guo C
Eur J Med Chem; 2018 May; 151():434-449. PubMed ID: 29649740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
